Summary by Moomoo AI
Biora Therapeutics, Inc. has filed a prospectus supplement on April 2, 2024, which updates and amends information from the original prospectus dated August 6, 2021, and the subsequent supplement dated June 14, 2023. The supplement pertains to the offering and sale of 1,509,343 shares of common stock and the amendment of existing warrants for the purchase of up to 3,018,868 shares. The amendments, effective March 31, 2024, include a reduction in the exercise price of the warrants from $5.05 to $1.10 per share, a condition that the warrants will not be exercisable until stockholder approval is obtained, and an extension of the expiration date to five years post-approval. The company's common stock is traded on the Nasdaq Global Market under the symbol 'BIOR', with the last reported sale price being $1.10 per share as of March 28, 2024. The prospectus supplement emphasizes the high degree of risk involved in investing in the securities and advises investors to read the risk factors discussed in the original prospectus and its amendments.